| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.07 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.08 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.08 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.08 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.093 | 0.08 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |